From April 11 to April 14, the fourth International specialized exhibition-forum Healthcare of the Urals – 2023 was held at the Ekaterinburg-Expo IEC, where the booths of the companies participating in the Ural Biomedical Cluster were presented again. 160 manufacturers and suppliers of medical products from 30 cities of Russia, which presented over a thousand pieces of various equipment, took part in the event.
In 2023, the Ural Biomedical Cluster admitted a collective member – the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region.
On January 31, 2023, a TASS press conference was held dedicated to the joint scientific and technological developments of the Ural State Medical University and industrial enterprises of the Sverdlovsk Region. The results of the implementation of the Priority 2030 program in 2022, the cooperation of the university with industrial enterprises of the region, as well as the project for creation of a full-cycle scientific and educational complex for the manufacture of medicines were discussed by Olga Kovtun, rector of USMU, Anatoly Sludnykh, General Director of the Ural Optical and Mechanical Plant, and Alexander Petrov, Chairman of the Board of Directors of the Medsintez Plant.
On November 26, 2022, the Medsintez Plant took part in the Scientific and Practical Conference of Pediatric Endocrinologists of the Sverdlovsk Region From Clinical Cases to Innovative Projects, dedicated to the 25th anniversary of the endocrinology department of the Regional Children's Clinical Hospital. Leading experts of Russia in the field of healthcare and endocrinology took part in the conference. At the exhibition of domestic pharmaceutical manufacturers, held within the framework of the conference, the Medsintez Plant presented analogue human insulin preparations Rosinsulin®. Doctors – pediatric endocrinologists and endocrinologists of healthcare organizations of the Sverdlovsk Region, the Ural Federal District and other regions of Russia noted the plant's contribution to the drug safety of the country.
Nonprofit Partnership "Ural Biomedical Cluster" was founded in December 2010 as a comprehensive innovative project. Its difference from an industrial cluster is that, in addition to manufacturing facilities, there are research centers, laboratories for preclinical studies, educational structures and clinics successfully operating based on the Cluster.
Strategic goal of the Ural Biomedical Cluster is to form a high-tech complex of interconnected production and infrastructure facilities for development, production and sale of modern medicines, medical equipment and high- quality medical devices in the Urals region.
The global mission of the Ural Biomedical Cluster is a widespread increase in availability of advanced medical technologies in Russia.
Today, the Ural Biomedical Cluster includes over 30 companies.
Ural Biomedical Cluster Services:
Management Patent search, detection of patented technologies, patent landscape designing, intellectual property protection, legal support.
Development and execution of a registration dossier, support, business planning, investor search, strategic planning.
Development and scaling of original formulations for pharmaceutical products and drugs, existing technologies transfer to a specific site (localization of production).
Personnel training upon request: master's degree, residency, advanced training courses, internships at the enterprises of the Cluster and partners.
Manufacturing of pharmaceutical products and medical devices to order.
Provision of office, laboratory and production premises, logistics services.
Articles of Association dated 24/9/2012